Terminal duct lobular unit involution of the normal breast: Implications for breast cancer etiology

Journal of the National Cancer Institute

Volumn 106, Issue 10, 2014, Pages

  Figueroa, Jonine D ^a   Pfeiffer, Ruth M ^a   Patel, Deesha A ^a   Linville, Laura ^a   Brinton, Louise A ^a   Gierach, Gretchen L ^a   Yang, Xiaohong R ^a   Papathomas, Daphne ^a   Visscher, Daniel ^b   Mies, Carolyn ^c   Degnim, Amy C ^b   Anderson, William F ^a   Hewitt, Stephen ^a   Khodr, Zeina G ^a   Clare, Susan E ^d   Storniolo, Anna Maria ^e   Sherman, Mark E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DUCT; CANCER DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; INVOLUTION; MIDDLE AGED; NULLIPARA; PATHOGENESIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TERMINAL DUCT LOBULAR UNIT; AGE; BREAST; BREAST TUMOR; COMPARATIVE STUDY; DISEASE PREDISPOSITION; HISTOLOGY; MAMMARY GLAND; PARITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POISSON DISTRIBUTION; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LOGISTIC MODELS; MAMMARY GLANDS, HUMAN; MIDDLE AGED; ODDS RATIO; PARITY; POISSON DISTRIBUTION; RISK ASSESSMENT; RISK FACTORS;

EID: 84985021334     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju286     Document Type: Article

References (50)

1. Russo J, Russo IH. Development of the human breast. Maturitas. 2004;49(1):2-15.
2. Hutson SW, Cowen PN, Bird CC. Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol. 1985;38(3):281-287.
3. Henson DE, Tarone RE. On the possible role of involution in the natural history of breast cancer. Cancer. 1993;71(6 Suppl):2154-2156.
4. Baer HJ, Collins LC, Connolly JL, et al. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer. 2009;115(7):1404-1411.
5. Ghosh K, Hartmann LC, Reynolds C, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol. 2010;28(13):2207-2212.
6. Ghosh K, Vachon CM, Pankratz VS, et al. Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst. 2010;102(22):1716-1723.
7. McKian KP, Reynolds CA, Visscher DW, et al. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009;27(35):5893-5898.
8. Milanese TR, Hartmann LC, Sellers TA, et al. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006;98(22):1600-1607.
9. Bartow SA, Pathak DR, Mettler FA, et al. Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors. Am J Epidemiol. 1995;142(8):813-819.
10. Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer. 2008;99(9):1369-1374.
11. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 1994;3(4):353-364.
12. Radisky DC, Hartmann LC. Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia. 2009;14(2):181-191.
13. Degnim AC, Visscher DW, Hoskin TL, et al. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat. 2012;133(1):169-177.
14. Sherman ME, Figueroa JD, Henry JE, et al. The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast. Cancer Prev Res (Phila). 2012;5(4):528-535.
15. Pardo I, Lillemoe HA, Blosser RJ, et al. Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank. Breast Cancer Res. 2014;16(2):R26.
16. Yang XR, Figueroa JD, Falk RT, et al. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res. 2012;14(2):R64.
17. Vierkant RA, Hartmann LC, Pankratz VS, et al. Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat. 2009;117(1):193-196.
18. Yang XR, Figueroa JD, Falk RT, et al. Analysis of Terminal Duct Lobular Unit (TDLU) Involution in Luminal A and Basal Breast Cancers. Breast Cancer Res. 2012;14(2):R64.
19. Cleveland WS. Robust Locally Weighted Regression and Smoothing Scatterplots. J Am Stat Assoc. 1979;74(368):8.
20. Lambert D. Zero-Inflated Poisson Regression, with an Application to Defects in Manufacturing. Technometrics. 1992;34(1):14.
21. McKelvey RD, Zavoina W. A statistical model for the analysis of ordinal level dependent variables. J Math Sociol. 1975;4:103-120.
22. Killick R, Fearnhead P, Eckley IA. Optimal Detection of Changepoints With a Linear Computational Cost. J Am Stat Assoc. 2012;107:9.
23. Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control. 2010;21(7):967-989.
24. Costarelli V, Yiannakouris N. Breast cancer risk in women: the protective role of pregnancy. Nurs Stand. 2010;24(18):35-40.
25. Lambe M, Hsieh C, Trichopoulos D, et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994;331(1):5-9.
26. Li CI, Beaber EF, Tang MT, et al. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat. 2013;137(2):579-587.
27. Millikan RC, Newman B, Tse CK, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109(1):123-139.
28. Work ME, John EM, Andrulis IL, et al. Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer. 2014;110(5):1367-1377.
29. Rosenberg LU, Einarsdottir K, Friman EI, et al. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2482-2488.
30. Palmer JR, Boggs DA, Wise LA, et al. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1883-1891.
31. Yang XR, Chang-Claude J, Goode EL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250-263.
32. Ma H, Bernstein L, Pike MC, et al. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a metaanalysis of epidemiological studies. Breast Cancer Res. 2006;8(4):R43.
33. Asselin-Labat ML, Vaillant F, Sheridan JM, et al. Control of mammary stem cell function by steroid hormone signalling. Nature. 2010;465(7299):798-802.
34. Turashvili G, Bouchal J, Burkadze G, et al. Mammary gland development and cancer. Cesk Patol. 2005;41(3):94-101.
35. Villadsen R. In search of a stem cell hierarchy in the human breast and its relevance to breast cancer evolution. APMIS. 2005;113(11-12):903-921.
36. Choudhury S, Almendro V, Merino VF, et al. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell. 2013;13(1):117-130.
37. Clarkson RW, Wayland MT, Lee J, et al. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res. 2004;6(2):R92-R109.
38. Strange R, Li F, Saurer S, et al. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development. 1992;115(1):49-58.
39. Russo J, Balogh GA, Heulings R, et al. Molecular basis of pregnancyinduced breast cancer protection. Eur J Cancer Prev. 2006;15(4):306-342.
40. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia. 2009;14(2):87-98.
41. Stein T, Salomonis N, Nuyten DS, et al. A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2009;14(2):99-116.
42. Asztalos S, Gann PH, Hayes MK, et al. Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila). 2010;3(3):301-311.
43. Callihan EB, Gao D, Jindal S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancyassociated breast cancer. Breast Cancer Res Treat. 2013;138(2):549-559.
44. Lyons TR, O'Brien J, Borges VF, et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med. 2011;17(9):1109-1115.
45. Beral V, Reeves G, Bull D, et al. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst. 2011;103(4):296-305.
46. Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-Analysis. Am J Med. 2008;121(6):501-508 e3.
47. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 1990;162(2):502-514.
48. Kaufman DW, Slone D, Rosenberg L, et al. Cigarette smoking and age at natural menopause. Am J Public Health. 1980;70(4):420-422.
49. Gu F, Caporaso NE, Schairer C, et al. Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev. 2013;22(1):58-68.
50. Stein T, Morris JS, Davies CR, et al. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res. 2004;6(2):R75-R91.